Ackman: No Plans to Sell Any Valeant `Crown Jewel' Assets -CNBC
03 5월 2016 - 2:34AM
Dow Jones News
Activist investor William Ackman on Monday said there will be no
"crown jewel" asset sales at Valeant Pharmaceuticals International
Inc. (VRX), but that the company would consider the sale on non
core assets.
Mr. Ackman, who holds a board seat at the drug company, also
told CNBC in an interview that Valeant's board "absolutely" would
take up the issue of potential roll backs to some of the company's
drug prices. The Valeant board, he said, would take up the issue
"promptly."
The Pershing Square Holdings Ltd. chief executive also said that
a renaming of the company is a possibility.
CNBC website: www.cnbc.com
Write to nymonitoring@dowjones.com
(END) Dow Jones Newswires
May 02, 2016 13:19 ET (17:19 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Pershing Square (EU:PSH)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Pershing Square (EU:PSH)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Pershing Square Holdings Ltd (유로넥스트 (Euronext))의 실시간 뉴스: 최근 기사 0
More Pershing News Articles